Latest Breaking News On - Annual goldman sachs global healthcare conference - Page 3 : comparemela.com

Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates

Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRachel mcminnHuman research ethics committeeNeurogene incAmerican society of geneDrug administrationExchange commissionResearch development rd expensesAustralian therapeutic goods administrationChief executive officerRecent highlightsAmerican societyCell therapyAnnual meetingAnnual goldman sachs global healthcare conferenceInternational rett syndrome foundation

Ionis to present at upcoming investor conferences

CARLSBAD, Calif., April 1, 2024 /PRNewswire/ Ionis Pharmaceuticals, Inc. today announced that management will participate in fireside chats at the following investor conferences: .

Ionis pharmaceuticals incPrnewswire ionis pharmaceuticals incBofa securities health care conferenceIonis pharmaceuticalsAnnual needham virtual healthcare conferenceMarkets global healthcare conferenceSecurities health care conferenceAnnual goldman sachs global healthcare conference

Why Shares of Vera Therapeutics Are Soaring Monday

The company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.

United statesVera therapeuticsAnnual goldman sachs global healthcare conferenceDana pointChinook therapeutics

Myriad Genetics to Participate in Goldman Sachs Healthcare Conference

07.06.2023 - SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and CEO, will participate in the 44th Annual Goldman Sachs Global .

Paulj diazGenetics incAnnual goldman sachs global healthcare conferenceMyriad genetics

Vir Biotechnology to Participate in the 44th Annual Goldman

SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief.

Vir biotechnology incMarianne de backerChief executive officerAnnual goldman sachs global healthcare conferenceNasdaq virVir biotechnologyGoldman sachs conferenceMarianne de backer